1 of 2nächste Seite

Kennzahlen

Key Data

 [Table 1.1]
 20082009Change
 € million€ million%
Bayer Group   
Sales32,91831,168-5.3
EBITDA16,2665,815-7.2
EBITDA before special items6,9316,472-6.6
EBITDA margin before special items21.1%20.8% 
EBIT23,5443,006-15.2
EBIT before special items4,3423,772-13.1
Income before income taxes2,3561,870-20.6
Net income1,7191,359-20.9
Earnings per share (€)32.221.70-23.4
Core earnings per share (€)44.173.64-12.7
Gross cash flow55,2954,658-12.0
Net cash flow63,6085,375+49.0
Net financial debt14,1529,691-31.5
Capital expenditures as per segment table1,9821,669-15.8
Research and development expenses2,6532,746+3.5
Dividend per Bayer AG share (€)1.401.400.0
Bayer HealthCare   
External sales15,40715,988+3.8
EBITDA13,6924,148+12.4
EBITDA before special items4,1574,468+7.5
EBITDA margin before special items27.0%27.9% 
EBIT22,1812,640+21.0
EBIT before special items2,7643,012+9.0
Gross cash flow53,0453,153+3.5
Net cash flow62,2593,431+51.9
Bayer CropScience   
External sales6,3826,510+2.0
EBITDA11,4501,311-9.6
EBITDA before special items1,6031,508-5.9
EBITDA margin before special items25.1%23.2% 
EBIT2918798-13.1
EBIT before special items1,0841,017-6.2
Gross cash flow51,1921,043-12.5
Net cash flow6736745+1.2
Bayer MaterialScience   
External sales9,7387,520-22.8
EBITDA11,041341-67.2
EBITDA before special items1,088446-59.0
EBITDA margin before special items11.2%5.9% 
EBIT2537 (266)
EBIT before special items586 (126)
Gross cash flow5850319-62.5
Net cash flow6782849+8.6

1 EBITDA: EBIT plus amortization of intangible assets and depreciation of property, plant and equipment. EBITDA, EBITDA before special items and EBITDA margin are not defined in the International Financial Reporting Standards and should therefore be regarded only as supplementary information. The company considers underlying EBITDA to be a more suitable indicator of operating performance since it is not affected by depreciation, amortization, write-downs/write-backs or special items. The company also believes that this indicator gives readers a clearer picture of the results of operations and ensures greater comparability of data over time. The underlying EBITDA margin is calculated by dividing underlying EBITDA by sales. See also “Calculation of EBIT(DA) Before Special Items.”

2 EBIT as shown in the income statement

3 Earnings per share as defined in IAS 33 = net income divided by the average number of shares. For details see Note [16] to the consolidated financial statements.

4 Core earnings per share is not defined in the International Financial Reporting Standards. The company believes that this indicator gives readers a clearer picture of the results of operations and ensures greater comparability of data over time. The calculation of core earnings per share is explained in Chapter 4.3.

5 Gross cash flow = income from continuing operations after taxes, plus income taxes, plus non-operating result, minus income taxes paid or accrued, plus depreciation, amortization and write-downs, minus write-backs, plus/minus changes in pension provisions, minus gains/plus losses on retirements of noncurrent assets, plus non-cash effects of the remeasurement of acquired assets. The change in pension provisions includes the elimination of non-cash components of the operating result. It also contains benefit payments during the year. See also “Liquidity and Capital Expenditures of the Bayer Group.”

6 Net cash flow = cash flow from operating activities according to IAS 7

top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
Search
Search
Download Center
 
 
Links
Services
 
 
 
 
Full Year 2009 Results
Info